Among COPD patients with elevated serum T-IgE, the occurrence of ABPA, ABPA-CB and ABPA-S was 6.2% (8/129), 3.9% (5/129) and 2.3% (3/129) respectively. This evidence concerns the gene IGHE and chronic obstructive pulmonary disease.